BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 28, 2019
View Archived Issues
Human TRIM5-alpha active against HIV
Read More
Immunogenicity aids chemotherapy as well
Read More
sEH activity is involved in offspring neurodevelopmental disorders after maternal immune activation
Read More
Identification of imidazopyrazine-derived TAK1 inhibitors with in vitro and in vivo efficacy
Read More
Dual inhibitor of CKI-alpha and -delta can help to control circadian rhythms
Read More
Inhibition of RIP1 kinase arrests demyelination progression at the stage of monocyte activation
Read More
Novel quinolylnitrone with antioxidant neuroprotective effect for ischemic stroke
Read More
Targeting intracellular PD-L1 strengthens checkpoint blockade
Read More
Probiotics for treating autism prepared at Beijing Jinfeng Labs Technology
Read More
Daiichi Sankyo initiates dosing in phase III AMELA study of mirogabalin
Read More
Kalyra Pharmaceuticals starts phase I study of KP-1199
Read More
Urovant Sciences launches international phase III COURAGE study of vibegron
Read More
Positive phase I/II mid-study results reported for ApoGraft
Read More
Bristol-Myers Squibb discovers STING agonists
Read More
New monoglyceride lipase inhibitors described by Abide Therapeutics
Read More
Angion Biomedica identifies Rho-associated protein kinase 1/2 inhibitors
Read More
Dana-Farber Cancer Institute presents new EGFR and/or HER2 inhibitors
Read More
New first-in-human study to explore use of ODM-209 in advanced prostate and breast cancers
Read More
Biohaven begins phase II study of BHV-3500 for acute treatment of migraine
Read More
Promising topline results from pivotal phase II study of enfortumab vedotin in urothelial cancer
Read More
C-peptide predicts diazoxide efficacy in neonates with hyperinsulinism hypoglycemia
Read More
Cancer Research UK, LifeArc and Ono establish immuno-oncology drug discovery alliance
Read More
S100A4 identified as a marker of polycystic ovary syndrome and treatment response
Read More
Tricida reports results from extension trial of TRC-101 in CKD patients with metabolic acidosis
Read More
Madrigal initiates phase III trial of MGL-3196 in NASH
Read More